Peptide Receptor Radionuclide Therapy in Patients With Differentiated Thyroid Cancer: A Meta-analysis.

Clinical Nuclear Medicine
Dong Yun Lee, Yong-Il Kim

Abstract

As patients with progressive medullary thyroid cancer (MTC) and radioiodine-refractory metastatic differentiated nonmedullary thyroid cancer (DTC) have poor prognoses and present therapeutic challenges, peptide receptor radionuclide therapy (PRRT) targeting the somatostatin receptor provides a promising option. This meta-analysis evaluated the therapeutic effects and outcomes of PRRT in differentiated thyroid cancer. PUBMED, EMBASE, CINAHL, SCOPUS, and COCHRANE were systematically searched using appropriate key words. The primary therapeutic effect was the radiological response after PRRT, and the objective response rate (ORR) and disease control rate (DCR) were identified in MTC and DTC, respectively. The outcome of serious adverse events (grade 3 or 4), additional therapeutic effects of F-FDG PET/CT and biochemical (calcitonin and thyroglobulin) responses, and radionuclides for PRRT were assessed as subgroup analyses. The parameters were generated as pooled proportions. Eleven articles with 165 patients were included (98 patients with MTC and 67 patients with DTC). PRRT achieved pooled proportions of ORR in 8.53% to 15.61%, DCR in 53.95% to 59.99%, and serious adverse events in 2.79% to 2.82% in MTC and DTC patients. F-FDG PE...Continue Reading

References

Apr 20, 2002·Seminars in Nuclear Medicine·Roelf ValkemaEric P Krenning
Apr 20, 2002·Seminars in Nuclear Medicine·Irene VirgoliniPietro Riva
Feb 14, 2003·Lancet·Steven I Sherman
Apr 8, 2004·Cancer Biotherapy & Radiopharmaceuticals·Lisa BodeiGiovanni Paganelli
Jan 7, 2005·The Journal of Clinical Endocrinology and Metabolism·Andreas MachensHenning Dralle
Jul 16, 2010·Clinical Oncology : a Journal of the Royal College of Radiologists·J A Sipos, E L Mazzaferri
Oct 26, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Samuel A WellsMartin J Schlumberger
Apr 6, 2012·Seminars in Nuclear Medicine·Richard P BaumCecilia Carreras
Sep 5, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rossella EliseiSteven I Sherman
Oct 10, 2013·Thyroid : Official Journal of the American Thyroid Association·Annibale VersariPaola Anna Erba
Apr 3, 2014·BMC Medical Research Methodology·Carson Ka-Lok LoMark Loeb
Aug 28, 2014·Journal of Clinical Imaging Science·Prashant JolepalemChing-Yee Oliver Wong
Oct 14, 2014·Endocrinology and Metabolism·June-Key Chung, Gi Jeong Cheon
Nov 19, 2014·Archivum Immunologiae Et Therapiae Experimentalis·Rafał CzepczyńskiMarek Ruchała
Dec 30, 2014·Clinical Nuclear Medicine·Fernanda VaismanRossana Corbo
Feb 12, 2015·The New England Journal of Medicine·Martin SchlumbergerSteven I Sherman
Feb 27, 2016·Endocrine-related Cancer·Yushan Mao, Mingzhao Xing
Apr 2, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·David A PattisonRodney J Hicks
Apr 1, 2017·European Journal of Nuclear Medicine and Molecular Imaging·Katja PinkerWolfgang A Weber
Jul 14, 2017·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Dania HirschCarlos A Benbassat
Sep 16, 2017·Best Practice & Research. Clinical Endocrinology & Metabolism·C ResteghiniL D Locati
Jan 23, 2018·Radiology·Hossein JadvarUmar Mahmood
Oct 23, 2018·Nuclear Medicine and Molecular Imaging·June-Key ChungGi Jeong Cheon
Oct 1, 2019·Endocrinology and Metabolism·Jierui LiuJun Liang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.